These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16948683)

  • 1. Estimating preventable fractions of disease caused by a specified biological mechanism: PAHs in smoking lung cancers as an example.
    Cox LA; Sanders E
    Risk Anal; 2006 Aug; 26(4):881-92. PubMed ID: 16948683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population.
    Pavanello S; Pulliero A; Saia BO; Clonfero E
    Mutat Res; 2006 Dec; 611(1-2):54-63. PubMed ID: 16978913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo[a]pyrene-7,8-9,10 diol epoxide.
    Fields WR; Desiderio JG; Leonard RM; Burger EE; Brown BG; Doolittle DJ
    Mol Carcinog; 2004 Jun; 40(2):79-89. PubMed ID: 15170813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of weekly oral oltipraz in chronic smokers.
    Kelley MJ; Glaser EM; Herndon JE; Becker F; Bhagat R; Zhang YJ; Santella RM; Carmella SG; Hecht SS; Gallot L; Schilder L; Crowell JA; Perloff M; Folz RJ; Bergan RC
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):892-9. PubMed ID: 15824161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
    Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.
    Arif JM; Dresler C; Clapper ML; Gairola CG; Srinivasan C; Lubet RA; Gupta RC
    Chem Res Toxicol; 2006 Feb; 19(2):295-9. PubMed ID: 16485906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trouble with smoking.
    Patterson M
    Nat Rev Genet; 2000 Dec; 1(3):168. PubMed ID: 11252744
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere.
    Haugen A; Becher G; Benestad C; Vahakangas K; Trivers GE; Newman MJ; Harris CC
    Cancer Res; 1986 Aug; 46(8):4178-83. PubMed ID: 3731085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen.
    Perlow RA; Broyde S
    J Mol Biol; 2001 Jun; 309(2):519-36. PubMed ID: 11371169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: a preliminary probabilistic assessment.
    Liao CM; Chio CP; Chen WY; Ju YR; Li WH; Cheng YH; Liao VH; Chen SC; Ling MP
    J Hazard Mater; 2011 Jun; 190(1-3):150-8. PubMed ID: 21458918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies to the benzo(a)pyrene diol epoxide-DNA adducts in sera from individuals exposed to low doses of polycyclic aromatic hydrocarbons.
    Galati R; Zijno A; Crebelli R; Falasca G; Tomei F; Iecher F; Carta P; Verdina A
    J Exp Clin Cancer Res; 2001 Sep; 20(3):359-64. PubMed ID: 11718215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
    Matter B; Wang G; Jones R; Tretyakova N
    Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genotoxic effect of carcinogenic PAHs, their artificial and environmental mixtures (EOM) on human diploid lung fibroblasts.
    Binková B; Srám RJ
    Mutat Res; 2004 Mar; 547(1-2):109-21. PubMed ID: 15013705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta.
    Manchester DK; Bowman ED; Parker NB; Caporaso NE; Weston A
    Cancer Res; 1992 Mar; 52(6):1499-503. PubMed ID: 1540958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers.
    Perera FP; Hemminki K; Young TL; Brenner D; Kelly G; Santella RM
    Cancer Res; 1988 Apr; 48(8):2288-91. PubMed ID: 3127049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of GSTM1 null and low repair XPC PAT+ on anti-B[a]PDE-DNA adduct in mononuclear white blood cells of subjects low exposed to PAHs through smoking and diet.
    Pavanello S; Pulliero A; Clonfero E
    Mutat Res; 2008 Feb; 638(1-2):195-204. PubMed ID: 18035379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.